论文部分内容阅读
目的临床观察经皮给药治疗仪对治疗小儿肺炎的疗效。方法下列有50例小儿肺炎患者,随机分为治疗组和对照组,其中每组各25例。对照组采用常规治疗方法 (应用抗生素静脉滴注及止咳、化痰、平喘等对症治疗);而治疗组在此基础上,采用经皮给药治疗仪治疗法,先将药片固定于左右肺俞穴上,并根据患者年龄大小及季节调节好所需的参数进行治疗。结果治疗组在退热、止咳、平喘、促进肺部啰音吸收及缩短病程方面疗效显著(P<0.01)。且总有效率明显高于对照组(P<0.01)。结论经皮给药治疗方法是新一代给药方式,它在治疗小儿肺炎方面疗效显著。
Objective To observe the effect of transdermal therapeutic apparatus on the treatment of children pneumonia. Methods The following 50 patients with pediatric pneumonia were randomly divided into treatment group and control group, of which 25 patients in each group. The patients in the control group were treated by conventional therapy (antibiotic infusion and antitussive, phlegm, asthma and other symptomatic treatment); while the treatment group on this basis, using transdermal therapeutic apparatus treatment, the first tablets fixed in the left and right lung Shu points, and according to the patient’s age and season to adjust the required parameters for treatment. Results The treatment group had a significant curative effect in relieving fever, relieving cough, relieving asthma, promoting pulmonary rales absorption and shortening the course of disease (P <0.01). The total effective rate was significantly higher than that of the control group (P <0.01). Conclusion Transdermal drug delivery is a new generation of drug delivery methods. It has a significant therapeutic effect on pediatric pneumonia.